Results 201 to 210 of about 20,935 (240)

Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity

Drug Metabolism Reviews, 2016

exaly  

Tetrahydrocannabinol as a Bronchodilator

Chest, 1977
Raja T. Abboud, Harvey D. Sanders
openaire   +2 more sources

Difference in tolerance development to hypothermia and pentobarbital-induced sleep prolongating effect of 11-hydroxy-Δ8-tetrahydrocannabinol and 11-oxo-Δ8-tetrahydrocannabinol in mice

European Journal of Pharmacology, 1982
Shizuo Narimatsu
exaly  

Rapid tolerance to Δ9-tetrahydrocannabinol and cross-tolerance between ethanol and Δ9-tetrahydrocannabinol in mice

European Journal of Pharmacology, 2001
G S Morato, Reinaldo N Takahashi
exaly  

Liquid chromatographic–mass spectrometric quantitation of Δ9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2004
Audra Stinchcomb, Satyanarayana Valiveti   +1 more
exaly  

Tetrahydrocannabinol

2006
openaire   +2 more sources

Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis

Clinical Therapeutics, 2018
Geert Jan Groeneveld
exaly  

Risperidone/tetrahydrocannabinol

Reactions Weekly, 2021
openaire   +1 more source

Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain

European Journal of Pharmacology, 1997
Raymond M Quock, Thomas H Burkey, P Consroe   +2 more
exaly  

Tetrahydrocannabinol

2009
openaire   +1 more source